These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 7708637)

  • 41. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.
    Roosihermiatie B; Nishiyama M; Nakae K
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):85-8. PubMed ID: 11023071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP; Ebrahim S; Pillay V
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 45. The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
    Visser ME; Texeira-Swiegelaar C; Maartens G
    Int J Tuberc Lung Dis; 2004 Feb; 8(2):260-2. PubMed ID: 15139457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Short-course treatment of tuberculosis on a 7-month schedule with an initial intensive phase of 1 month (TA-81)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1984 Mar; 112(3):290-5. PubMed ID: 6473971
    [No Abstract]   [Full Text] [Related]  

  • 48. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 49. [Tuberculosis treatment today].
    Sjögren I; Boman G; Löfdahl CG; Skoogh BE
    Lakartidningen; 1984 Dec; 81(49):4655-9. PubMed ID: 6521569
    [No Abstract]   [Full Text] [Related]  

  • 50. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
    Gomi J; Aoyagi T
    Scand J Respir Dis Suppl; 1973; 84():145-52. PubMed ID: 4522070
    [No Abstract]   [Full Text] [Related]  

  • 51. Tuberculosis and renal transplantation.
    Zaragoza RM; Hernandez A; Treviño M; Diliz HS; Alvarez L
    Transplant Proc; 1996 Dec; 28(6):3309. PubMed ID: 8962285
    [No Abstract]   [Full Text] [Related]  

  • 52. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
    Baba H; Schinkai A; Izuchi R; Azuma Y
    Kekkaku; 1986 Jul; 61(7):371-7. PubMed ID: 3761792
    [No Abstract]   [Full Text] [Related]  

  • 54. Intermittent rifampicin treatment of tuberculosis.
    Riska N; Mattson K
    Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
    [No Abstract]   [Full Text] [Related]  

  • 55. [New regimens in chemotherapy of primary tuberculosis in children].
    Sibila S; Fierbinţeanu O
    Rev Pediatr Obstet Ginecol Pediatr; 1977; 26(1):79-84. PubMed ID: 404693
    [No Abstract]   [Full Text] [Related]  

  • 56. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 57. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

  • 58. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 59. [Principles in the performance of chemotherapy in dispensary group VI children and adolescents].
    Ovsiankina ES; Gubkina MF; Kuz'mina IK; Stakheeva LB; Borodina NN; Zaletina EIu
    Probl Tuberk Bolezn Legk; 2007; (8):25-8. PubMed ID: 17915463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Myrin P in the combined treatment of tuberculosis].
    Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD; Zeliger LR; Elistratova NA
    Antibiot Khimioter; 2002; 47(6):22-7. PubMed ID: 12422644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.